A series of novel pyrimidine functionalized palladium(II)(NHC) complexes with aryl and alkyl substituents [1-(2-Pyrimidyl)-3-( aryl or alkyl )imidazoline-2-ylidene palladium(II) chlorides] was synthesized by transmetalation via the corresponding silver complexes. All compounds have been fully characterized by 1 H and 13 C NMR spectroscopy, elemental analysis, and in two cases by X-ray single crystal structures. Different solid state structures were observed for aryl and alkyl substituted ligands: for the sterically less demanding methyl substituent, a complex is formed, where two ligands are coordinated to one metal center [Pd(L) 2 Cl] +, while in the mesityl case a [Pd(L)Cl 2 ] structure was observed. They show good catalytic activity in the CH activation of methane as well as in the Mizoroki-Heck reaction, where especially the methyl substituted complex shows a remarkably high activity combined with a very high selectivity.
No takes yet. Share an insight, caveat, or question.
Meyer et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: